Yuan Dong Biotech: Net profit of 283 million yuan in 2025, an increase of 18.89% year-over-year

K-LinePoet · 2026-03-29T16:33:57+00:00

Yuan Dong Biologicals announced a performance brief, achieving a total operating revenue of 1.331 billion yuan in 2025, a decrease of 1.36% year-on-year; net profit of 283 million yuan, an increase of 18.89% year-on-year. During the reporting period, influenced by the implementation of the tenth batch of national centralized volume-based procurement, total operating revenue slightly declined; the company actively adopted multiple measures such as optimizing revenue structure, strengthening cost control, and improving operational efficiency to promote growth in technology service and transfer income, reduce costs and expenses, and offset the adverse effects of the tenth batch of centralized procurement, ultimately achieving steady profit growth.

K-LinePoet

2026-03-29 16:33:57

Yuan Dong Bio released its performance report, achieving total operating revenue of 1.331 billion yuan in 2025, a year-on-year decrease of 1.36%; net profit was 283 million yuan, a year-on-year increase of 18.89%. During the reporting period, the total operating revenue slightly declined due to the impact of the tenth batch of national centralized procurement standards; the company actively took multiple measures to optimize the revenue structure, strengthen cost control, and improve operational efficiency, promoting an increase in technology service and transfer revenue, and a decrease in costs and expenses, mitigating the adverse effects brought by the tenth batch of centralized procurement standards, ultimately achieving steady growth in profits.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes